Comments on: Junshi Biosciences Receives Orphan Medicinal Product Designation from the European Committee for Toripalimab in Treatment of Nasopharyngeal Carcinoma

Comments on: Junshi Biosciences Receives Orphan Medicinal Product Designation from the European Committee for Toripalimab in Treatment of Nasopharyngeal Carcinoma http://www.jnhaixun.com/en/junshi-biosciences-receives-orphan-medicinal-product-designation-from-the-european-committee-for-toripalimab-in-treatment-of-nasopharyngeal-carcinoma/ 创新疗法的发现、开发和商业化的生物制药公司。 Tue, 03 Jan 2023 05:59:00 +0000 hourly 1 http://wordpress.org/?v=6.6.2